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Abstract
Background: Site-specific protein labeling or modification can facilitate the characterization of proteins with respect to their
structure, folding, and interaction with other proteins. However, current methods of site-specific protein labeling are few
and with limitations, therefore new methods are needed to satisfy the increasing need and sophistications of protein
labeling.
Methodology: A method of protein C-terminal labeling was developed using a non-canonical split-intein, through an intein-
catalyzed trans-splicing reaction between a protein and a small synthetic peptide carrying the desired labeling groups. As
demonstrations of this method, three different proteins were efficiently labeled at their C-termini with two different labels
(fluorescein and biotin) either in solution or on a solid surface, and a transferrin receptor protein was labeled on the
membrane surface of live mammalian cells. Protein biotinylation and immobilization on a streptavidin-coated surface were
also achieved in a cell lysate without prior purification of the target protein.
Conclusions: We have produced a method of site-specific labeling or modification at the C-termini of recombinant proteins.
This method compares favorably with previous protein labeling methods and has several unique advantages. It is expected
to have many potential applications in protein engineering and research, which include fluorescent labeling for monitoring
protein folding, location, and trafficking in cells, and biotinylation for protein immobilization on streptavidin-coated surfaces
including protein microchips. The types of chemical labeling may be limited only by the ability of chemical synthesis to
produce the small C-intein peptide containing the desired chemical groups.
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Introduction
Proteomics has become one of the fastest growing fields in life
science research, and the demand for tools to analyze proteins has
increased substantially. Engineering and modifying proteins in vivo
or in vitro can aid the understanding of the biological function and
structure-function relationship of proteins. Labeling a protein witha
chemical entity, such as a fluorescent group, can facilitate protein
characterization with respect to the protein’s three-dimensional
structure, folding behavior, and interaction with other proteins.
Although protein labeling and modification are invaluable tools of
protein engineering and extremely useful throughout life science, a
major challenge is the addition of a chemical label or moiety site-
specifically to a protein. Standard chemical labeling methods often
produced mixed populations of labeled proteins, because the
targeted amino acid side chains (thiols, carboxyls, amines) were
present more than once in the protein of interest. One chemical
method can target the N-terminus of a protein specifically [1],
however it requires the N-terminus to be solvent-exposed and also
depends on the nature of the N-terminal amino acid side chain.
Alternative methods have been developed to label recombinant
proteins, with limited successes. In one type of method, certain
ligand-binding polypeptide tags were fused with target proteins in
recombinant fusion proteins to achieve non-covalent binding of a
fluorescent ligand [2], a labeled polypeptide ligand [3], or other
small molecule ligands [4–6]. These methods are relatively simple
to use, but the non-covalent labeling can be unstable, and the
presence of the polypeptide tag in the labeled protein may
interfere with protein function. In a second type of method, certain
polypeptide or protein tags were appended to a target protein, and
an enzymatic reaction was used to covalently attach a fluorescent
substrate molecule to the polypeptide or protein tag. Enzymes
used in these methods included O
6-alkylguanine DNA alkyl
transferase [7], phosphopantetheine transferases [8,9], biotin
ligase [10], transglutaminase [11], and sortase [12]. These
methods produce stable covalent labeling of proteins, however
the polypeptide or protein tags are retained in the labeled protein,
which may interfere with protein function. Another elegant
method was to incorporate an unnatural or labeled amino acid
into a protein during translation [13], which could label or modify
a protein seamlessly without an extra polypeptide tag in the
labeled protein. However, a specially engineered translation or
tRNA charging system is needed for each unnatural amino acid,
which increases the technical complexity of this method and limits
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8381the type of labels or modifications that can be introduced into
proteins.
An intein-based protein cleavage reaction was used cleverly to
generate a thioester at the C-terminus of recombinant proteins,
which led to specific labeling of the protein C-terminus in a
subsequent chemical reaction. Inteins are protein sequences
embedded within a host protein, from which the intein catalyzes
a protein splicing reaction to excise itself and concomitantly ligate
the flanking host protein sequences (N- and C-exteins) [14]. In the
absence of a C-extein or splicing, an intein can catalyze a cleavage
reaction at its N-terminus, which can be harnessed to create a
thioester at the C-terminus of N-extein [15,16]. This thioester, in
the expressed protein ligation method [17], can react with the N-
terminal cysteine residue of a polypeptide to achieve protein
ligation [17], or with labeled cysteine analogues [18,19] and
bifunctional azides in combination with labeled alkynyl com-
pounds [20] to achieve C-terminal labeling of the N-extein (target
protein). A limitation of this method is that it generally requires or
introduces a cysteine residue into the labeled protein. In addition,
this thioester reaction is not an enzymatic reaction and therefore
has some of the limitations common to chemical reactions, such as
requiring a relatively high protein concentration.
Protein trans-splicing, which is catalyzed by split-inteins,
provides another avenue for protein labeling. A split-intein
consists of an N-intein and a C-intein, which can associate non-
covalently to reconstitute the active intein [21,22]. A trans-splicing
reaction takes place between two polypeptides, with one
polypeptide consisting of an N-extein fused to the N-intein, and
with another polypeptide consisting of the C-intein fused to a C-
extein. The trans-splicing reaction excises the two inteins and
concomitantly ligates the two exteins with a peptide bond. To
achieve protein C-terminal labeling, a target protein containing an
N-intein has been successfully trans-spliced with a synthetic peptide
containing a C-intein [23,24], using the naturally occurring Ssp
DnaE split-intein. However, the N-intein and C-intein of this and
other conventional split-inteins are typically larger than 100 and
35 aa, respectively, which makes it difficult and expensive to
produce the synthetic labeling peptide containing the N- or C-
intein. Recently a non-canonical split-intein (Ssp DnaB S1) was
engineered to have a small (11 aa) N-intein and a large (.120 aa)
C-intein [25], and it has been used successfully in a trans-splicing
reaction to label the N-terminus of recombinant proteins in vitro
[26] and on the surface of mammalian cells [27]. However this
trans-splicing method cannot be used to label the C-terminus of
proteins, because the C-intein is too large to be included in a
synthetic labeling peptide.
In this report we aim to produce a method for the C-terminal
labeling of recombinant proteins, using an intein-catalyzed trans-
splicing reaction between a protein and a small synthetic peptide
carrying the desired labeling groups. For this purpose, we took
advantage of the recently reported non-canonical split-intein (Ssp
GyrB S11) that consisted of an extremely small (6 aa) C-intein and
a large (150 aa) N-intein [28]. We showed for the first time that
this S11 split-intein could trans-splice proteins with synthetic
peptides containing different chemical modifications, although it
had been shown before to trans-splice a protein with only an
unmodified peptide. We achieved site-specific labeling of different
recombinant proteins at the C-terminus both in vitro and in vivo on
cell surfaces. Our findings produced a general method for site-
specific and efficient chemical labeling or modification of
recombinant proteins, which has a number of unique advantages
over previously reported methods. Potential usefulness of this
method in protein engineering and research are discussed.
Results
Protein C-terminal labeling through trans-splicing with a
labeled synthetic peptide
A strategy of protein C-terminal labeling was designed and
shown in Figure 1, by taking advantage of the recently engineered
Figure 1. Schematic illustration of the method of protein C-terminal labeling. The precursor protein is a recombinant fusion protein
consisting of the target protein (TP) to be labeled, the 150-aa N-intein (IN) of the Ssp GyrB S11 split-intein for trans-splicing, and an affinity binder (AB)
for easy purification of the precursor protein. The synthetic peptide consists of the 6-aa C-intein (IC) of the Ssp GyrB S11 split-intein for trans-splicing,
followed by a serine residue (highlighted in red), a small linker sequence (blue box), and the labeling group (L) linked to the side chain of a suitable
amino acid X. The N-intein and the C-intein are presented in presumed ribbon structures derived from the conserved intein crystal structure of the
Ssp DnaB mini-intein intein [41], illustrating their association through structural complementation to reconstitute an active intein that catalyzes a
trans-splicing reaction to produce the labeled protein and the excised inteins.
doi:10.1371/journal.pone.0008381.g001
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contains the 150-aa N-intein (IN) sandwiched between a target
protein and an affinity binder that facilitates purification of the
precursor protein. A synthetic peptide contains the 6-aa C-intein
(IC) followed by a small linker and the labeling group. The short
linker begins with a nucleophilic amino acid residue (Serine in this
case) required for the splicing reaction. When the precursor
protein and the synthetic peptide are incubated together, the large
N-intein and the small C-intein are expected to recognize one
another, associate non-covalently, form an active intein confor-
mation, and catalyze a protein trans-splicing reaction. As a result,
the C-terminus of the target protein will be joined through a
peptide bond to the small linker followed by the labeling group,
with the N-intein (followed by the affinity binder) and the C-intein
excised.
To demonstrate the above strategy of C-terminal labeling, a
precursor protein and a labeling peptide were produced. The
precursor protein MINC, which was produced through recombi-
nant DNA and gene expression in E. coli, contained a maltose
binding protein (M) as the target protein, a chitin binding domain
(C) as the affinity binder, and the N-intein sequence (IN) in the
middle (Figure 2A). The precursor protein was purified using
amylose resin, although it could also be purified using chitin beads
(see below). The labeling peptide IC-L was a 12-aa synthetic
peptide having the sequence GVFVHNSAGSGK-L, in which
GVFVHN was the C-intein, SAGSGK was the C-extein (or
linker), and L was the labeling group (5-carboxy-fluorescein;
lexc=492 nm, lem=517 nm) linked to the side chain of the lysine
(K) residue of the C-extein.
The MINC precursor protein was incubated with the IC-L
labeling peptide in a splicing buffer at room temperature for
16 hours to achieve trans-splicing. Analysis of the reaction
products, by SDS-polyacrylamide gel electrophoresis and Western
blotting using antibodies against the chitin binding domain (anti-C
antibodies), revealed two new protein bands that corresponded in
size to the predicted products of the trans-splicing reaction
(Figure 2B). They were the spliced protein M
L (the target protein
with the C-terminal labeling group) and the excised N-intein (the
INC fragment), while the excised C-intein was too small (6 aa) to
be seen on the gel. The M
L protein showed the expected green
fluorescence in a fluorescence scan (Figure 2B), while the precursor
protein and the excised N-intein did not, all as predicted. Diffusive
background fluorescence was also visible in the fluorescence scan,
but it did not correspond to a labeled protein species, as the
Coomassie-stained gel did not show a protein band at the
corresponding position.
A significant amount of the precursor protein remained,
indicating that the trans-splicing reaction did not go to completion.
The splicing efficiency, which was defined as the percentage of the
precursor protein that underwent splicing, was estimated to be
,30%, but increased to ,70% when the reducing agent TCEP
was present in the splicing buffer. Kinetic analysis of the labeling
reaction between MINC protein and IC-L peptide revealed pseudo
first-order rate constants kobs of (5.060.7)610
25 s
21 and
(3.860.6)610
25 s
21 in the absence and presence of TCEP,
respectively (Figure 2C).
The spliced protein M
L was further identified through mass
spectrometry analyses. An electron spray ionization mass spec-
trometry (ESI-MS) analysis of the M
L protein determined a
molecular mass of 43814.0 Da (Figure 3A), which was in close
agreement with the calculated mass of 43830.7 Da. After trypsin
digestion of the M
L protein, an ESI-MS analysis revealed an
[M+2H]
2+ peptide ion having a deconvoluted mass of 1378.0 Da,
which corresponded well with the calculated mass (1378.964 Da)
Figure 2. Protein C-terminal labeling with a fluorophore. A. Schematic illustration of the labeling reaction. IN and IC: components of the Ssp
GyrB S11 split-intein. M: maltose binding protein as the target protein to be labeled. C: chitin-binding domain as the affinity binder for purification of
the precursor protein. L: 5-carboxyfluorescein as the labeling group. In the synthetic peptide IC-L, IC is connected to L by the sequence SAGSGK, with L
attached to the side chain of the K (lysine) residue. B. Analysis of the labeling results. The purified precursor protein was incubated at room
temperature for 16 hours, with or without the peptide and the reducing agent TCEP, as indicated. The reaction products were resolved through SDS-
PAGE and visualized either by Coomassie staining, by Western blotting using anti-C antibodies, or by fluorescence scan (excitation at 488 nm, filter
for 520 nm). Positions of the precursor protein (MINC), the labeled protein (M
L), and the excised N-intein (INC) are indicated. In lane 1, a minor protein
band at the same position as M
L is the endogenous E. coli maltose binding protein that is known to be co-purified in the amylose affinity
chromatography. C. Time-course of the reaction between MINC precursor protein and IC-L peptide in the presence or absence of TCEP. Labeling
efficiency was calculated from densitometry analysis on anti-C Western blots. Error bars represent standard deviations from triplicate experiments.
doi:10.1371/journal.pone.0008381.g002
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L. A. ESI-MS analysis of the labeled
protein. The determined molecular weight of 43814 Da was in close agreement with the calculated mass (43830.7 Da) of the labeled protein M
L. B.
MS/MS analysis of the labeled protein after trypsin digestion. The deconvoluted spectrum of a 1378-Da peptide corresponded well to the calculated
mass (1378.964 Da) of the C-terminal peptide of M
L. The y-fragment ions of this peptide yielded to the amino acid sequence given below the
spectrum, which unambiguously identified the trans-spliced peptide at the C-terminus of the labeled M
L protein.
doi:10.1371/journal.pone.0008381.g003
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M
L. The amino acid sequence of this C-terminal trypsin peptide
was determined by tandem mass spectrometry (MS/MS) analysis
to be GTLEGGSAGSG (Figure 3B), in which GTLEGG matched
the C-terminal sequence of the M protein, and SAGSG matched
the C-extein sequence of the IC-L peptide, all as expected. The C-
terminal Lys residue with the fluorophore was also revealed as a
fragment ion of 504.2 Da, which matched closely with the
calculated mass of 505.91 Da. All together, these mass
spectrometry analyses clearly identified the spliced protein, which
confirmed a successful production of the fluorescently labeled M
L
protein by trans-splicing.
Distinguishing trans-splicing from N-cleavage
Protein trans-splicing may sometimes be accompanied by N- or
C-cleavages as undesirable side reactions, in which the peptide
bond at the intein’s N- or C-terminus is broken without forming a
new peptide bond as in splicing. In this study, the spliced (labeled)
protein band (M
L) in Figure 2B could possibly be a mixture of the
splicing product and the N-cleavage product, because these two
protein products had similar molecular masses (43830.72 Da and
42984.47 Da, respectively). To test this possibility, the following
experiments were carried out.
Protein products of the C-terminal labeling reaction were
digested with the site-specific protease Factor Xa to produce a
short C-terminal peptide. As illustrated in Figure 4A, this peptide
from the splicing (C-terminally labeled) product would have a
molecular mass of 1378 Da, whereas the peptide from the N-
cleavage product would have a molecular mass of 532 Da. This
size difference and the highly hydrophobic nature of the
fluorescein on the C-terminally labeled peptide allowed easy
separation of the two peptides by reverse phase high-performance
liquid chromatography (RP-HPLC). As shown in Figure 4B, the
RP-HPLC analysis revealed a single strong signal (peak) of the C-
terminal labeled peptide corresponding to the splicing product. No
signal was observed for the unlabeled peptide corresponding to the
N-cleavage product, whose position was predicted using a control
peptide, indicating that there was no detectable amount of the N-
cleavage product.
Further detection of possible N-cleavage product was also
carried out, using a more sensitive method. Protein products of the
above C-terminal labeling reaction, after digestion with protease
Factor Xa, were analyzed by liquid chromatography (under
conditions different from the above RP-HPLC) followed by
tandem mass spectrometry (LC-MS/MS). As shown in
Figure 4C, the liquid chromatography revealed a large peak
corresponding to the labeled peptide from splicing and a tiny peak
corresponding to the unlabeled peptide from N-cleavage, with
both peptides being identified through MS/MS analysis (data not
shown). The relative peak areas of the two peptides were measured
to be 7.14610
7 and 5.75610
9, respectively, which were used to
estimate the relative amounts of the spliced (labeled) product and
the N-cleavage product. Based on this estimation, the labeling
(trans-splicing) reaction made up ,98.7% of the total, while the N-
cleavage reaction made up the remaining ,1.3%.
Purification of C-terminally labeled protein
We then showed that the target protein M could be labeled in
and purified from a cell lysate in a single chromatographic step,
which takes advantage of the affinity binder (chitin-binding
domain in this case) fused to the C-terminal of the N-intein in
the MINC protein. To achieve this, the MINC protein in an E. coli
cell lysate was immobilized on chitin beads, the unbound proteins
were washed away, and the beads were subsequently incubated
with the labeling peptide IC-L. The subsequent trans-splicing
reaction produced and simultaneously released the labeled protein
M
L from the chitin beads (Figure 5A). The elution fraction also
contained some MINC precursor protein, which likely fell off the
chitin resin during the prolonged labeling incubation and could be
removed by a subsequent passage of the sample through fresh
chitin resin. The resulting purified M
L protein was able to bind to
amylose resin (Figure 5B) and could subsequently be eluted with
maltose-containing buffer (Figure 5C), which showed that the
covalent attachment of 5-carboxyfluorescein to the C-terminus of
the maltose binding protein did not interfere with the protein’s
biochemical function.
Protein C-terminal biotinylation through peptide splicing
Because protein biotinylation can be an effective way of protein
immobilization on streptavidin-coated protein chips [19,30], we
tested whether our labeling method could achieve C-terminal
biotinylation of recombinant proteins. For this purpose, we
produced a synthetic peptide IC-B having the sequence
GVFVHNSAGSK-(Biotin), in which GVFVHN was the C-intein,
SAGSK was the C-extein (or linker), and biotin was linked to the
side-chain of the C-terminal Lys residue. Two new precursor
proteins were also constructed, in addition to the MINC precursor
protein described above, in order to assess the versatility of the C-
terminal biotinylation reaction. The EINH precursor protein
contained an enhanced Green Fluorescent Protein (E) as the target
protein, whereas in GST-ACP-INC the target protein was a fusion
of a Glutathione-S-transferase (GST) and an acyl carrier protein
(ACP). To facilitate protein purification and identification, the Ssp
GyrB S11 IN sequence was followed either with a hexa-histidine
tag (H) in the EINH protein or a chitin binding domain (C) in the
GST-ACP-INC protein.
A trans-splicing reaction of each precursor protein with the IC-B
peptide produced a biotinylated protein, as revealed by Western
blot analysis using antibodies against biotin (Figure 6A). The
apparent sizes of these three biotinylated proteins matched closely
with their predicted molecular weights, which were 43 kDa, 27
kDa, and 39 kDa, respectively, for target proteins generated from
the MINC, EINH, and GST-ACP-INC precursor proteins. To
estimate the efficiencies of the protein biotinylation, Western blots
were carried out using antibodies against the chitin binding
domain (C) for reactions involving MINC and GST-ACP-INC, or
using antibodies against the hexa-histidine tag (H) for reactions
involving EINH. After estimating the quantities of the precursor
protein and the biotinylated protein on these Western blots, the
efficiencies of the protein biotinylation was calculated to be 30–
50% for the three different precursor proteins (Figure 6B).
To test whether the C-terminally biotinylated protein could be
immobilized on a streptavidin-coated surface, we carried out co-
purificational C-terminal biotinylation of the enhanced green
fluorescent protein (Figure 7A). The precursor protein EINC was
first bound to chitin beads (column) through its chitin binding
domain and then incubated with the IC-B peptide to allow on-
column trans-splicing, which biotinylated and simultaneously
released the target protein. When this biotinylated protein was
incubated with streptavidin-coated beads, strong green fluores-
cence was observed on the surface of the beads, indicating binding
of the protein to the beads. In a negative control, no green
fluorescence appeared on the bead surface after incubation with E.
coli cell lysate containing the EINC precursor protein without
biotinylation.
We then tested whether the protein C-terminal biotinylation
and the immobilization on a solid surface could be achieved in one
step when the IC-B peptide was pre-bound to the streptavidin-
Intein-Based Protein Labeling
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incubated with the IC-B peptide to allow binding. After washing
away any excessive unbound peptide, the beads were incubated
with E. coli cell lysate containing the EINC protein to allow trans-
splicing. After washing away any unbound protein, the beads
showed bright green fluorescence, indicating that the enhanced
green fluorescent protein was immobilized to the beads as a result
of trans-splicing between the EINC precursor protein and the pre-
bound IC-B peptide. In a negative control, no bright green
fluorescence was observed when the same cell lysate was incubated
with streptavidin-coated beads without the pre-bound IC-B
peptide, and the dim green fluorescence was due to autofluores-
cence of streptavidin beads after the prolonged exposure time.
Fluorescent labeling of a cell surface receptor protein
We tested whether the C-terminal labeling method could label
proteins on the surface of live cells under nearly physiological
conditions. Human transferrin receptor (TfR) was chosen as the
target protein, because the C-terminus of this well characterized
protein is on the outer surface of the cell membrane. A
recombinant fusion protein (TfR-IN-HA), which consisted of
TfR followed by the Ssp GyrB S11 IN sequence and a C-terminal
Figure 4. Detection of possible N-cleavage as a side reaction. A. Illustration of the detection strategy. The predicted N-cleavage product M
C is
compared with the trans-splicing (C-terminally labeled) product M
L. Site-specific cleavage of M
C and M
L with protease Factor Xa releases the C-
terminal peptide pep
Xa and pep
Xa-L, respectively. B. RP-HPLC analysis. The left chromatogram shows a synthetic pep
Xa used as a standard. The middle
and right chromatograms show the sample peptide detected at 210 nm (middle) and 497 nm (right). The increasing baseline absorbance at 497 nm
over time was most likely due to the absorbance of the increasing concentration of the mobile phase B solution. C. MS-coupled HPLC analysis. The
pep
Xa-L was much more abundant than pep
Xa, and both peptides were identified by their corresponding molecular weights in mass spectrometry
analysis (data not shown).
doi:10.1371/journal.pone.0008381.g004
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hamster ovary cells (CHO-TRVb [31]) through plasmid transfor-
mation, as evidenced by immunofluorescence and Western
blotting (Figure 8A). Presence of this TfR-IN-HA protein on the
cell surface, which was a prerequisite for the C-terminal labeling
reaction, was further confirmed by the cellular uptake of
rhodamine-labeled transferrin Rh-Tf (Figure 8B).
To carry out fluorescent labeling of the transferrin receptor, the
above CHO-TRVb cells expressing the TfR-IN-HA fusion protein
were incubated with an increasing amount of IC-L peptide. After
washing away any excessive IC-L peptide, confocal microscopy
revealed discrete green fluorescent spots associated with the cells
(Figure 8C), indicating a successful fluorescent labeling of the
transferrin receptor protein through a trans-splicing reaction
between the TfR-IN-HA fusion protein and the IC-L peptide.
The green fluorescence was sometimes observed inside the cell
additional to the cell surface, and this was consistent with
endocytic internalization of the labeled transferrin receptor
protein, which is a known function of the transferrin receptor
protein [32,33]. In a negative control, cells transfected with empty
vector (pcDNA3.1), did not show any green fluorescence.
Discussion
We have demonstrated an efficient method of protein C-
terminal labeling, by trans-splicing recombinant proteins with
synthetic peptides containing the labeling moieties. This trans-
splicing method is uniquely suitable for protein C-terminal
labeling, in contrast to a previously reported trans-splicing method
using the S1 split-intein for protein N-terminal labeling [26,29].
This method has the following three advantages, when compared
to previous trans-splicing methods using conventional split-inteins
having a larger (.30 aa) C-intein. First, it uses an extremely small
(6 aa) C-intein that can be accommodated in a synthetic peptide
more easily and economically, particularly when the synthetic
peptide needs to contain large and complex labeling groups.
Second, the 6-aa S11 C-intein is free of amino acid residues
commonly used for chemical modification (Lys, Cys, Glu),
therefore any one or a combination of these residues may be
added after the C-intein in the synthetic peptide to serve as specific
site(s) for chemical attachment of desired labeling group(s). Third,
the N-intein of the S11 split-intein resembles more closely the
Figure 5. On-column production of M
L protein. A. The co-
purification labeling process was monitored through SDS-PAGE analysis
with Coomassie blue staining or fluorescence scanning as indicated.
Lanes 1 and 2: total E. coli proteins before and after IPTG-induced
expression of the precursor protein MINC, respectively. Lane 3: soluble
fraction of the cell lysate of lane 2. Lane 4: proteins of lane 3 bound to
chitin beads. Lane 5: proteins released from the chitin beads of lane 4
after an overnight incubation with the labeling peptide IC-L in the
presence of TCEP. B. Amylose resin was incubated with (panels 1 and 2)
or without (panels 3 and 4) the purified M
L protein. Panels 1 and 3 are
differential interference contrast images, while panels 2 and 4 are
fluorescence images. C. SDS-PAGE analysis of the M
L protein fractions
eluted from the amylose resin of panels 3 and 4 of B using a maltose-
containing elution buffer.
doi:10.1371/journal.pone.0008381.g005
Figure 6. C-terminal biotinylation using the Ssp GyrB S11 split-
intein. A. The three precursor proteins (MINC, EINH, and GST-ACP-INC)
were incubated with (+) or without (2) the peptide IC-B in the presence
of 0.1 mM TCEP for 18 h at room temperature, and the reaction
products were analyzed by Western blotting using antibodies against
biotin. From the three precursor proteins, the three target proteins for
biotinylation were a maltose binding protein (M, 43 kDa), an enhanced
green fluorecent protein (E, 27 kDa), and a glutathione-S-transferase/
acyl carrier fusion protein (GST-ACP, 39 kDa), respectively. B. Efficiency
of C-terminal biotinylation of the three target proteins as determined
by densitometry analysis on Western blots using anti-C antibodies (for
MINC and GST-ACP-INC) and anti-H antibodies (for EINH). Error bars
represent standard deviations from triplicate experiments.
doi:10.1371/journal.pone.0008381.g006
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protein. In a previously reported ‘‘cysteine tag’’ method of intein-
mediated protein C-terminal labeling [34,35], a cysteine-contain-
ing recombinant protein was used as the label carrier. In contrast,
the trans-splicing method of this study uses a synthetic peptide as
the label carrier, which can be advantageous in terms of the larger
number of labeling moieties that can be chemically synthesized.
When compared to the expressed protein ligation (EPL) method
[17], the trans-splicing method of this study does not require a Cys
residue at the site of the protein-peptide ligation, and it is
completely an enzymatic reaction that can work with very low
protein concentrations under gentle or physiological conditions.
Consistent with this notion, the labeled proteins in this study
retained their original biochemical functions (ligand binding,
epifluorescence), and a receptor protein was successfully labeled on
the membrane surface of live mammalian cells.
The C-terminal labeling method of this study adds only a
minimal amount of extra sequence to the labeled protein, in
contrast to some other labeling methods that add a large
polypeptide sequence (up to hundreds of amino acids) to the
labeled protein [7–10]. This can be a considerable advantage,
because adding a minimal extra sequence minimizes the risk of
hindering normal functions of the labeled protein. In the trans-
splicing method of this study, only the small C-extein is trans-
spliced onto the C-terminus of the target protein, while the C-
intein and the N-intein are excised and not present in the labeled
protein. In the IC-L peptide used in this study, the 6-aa C-extein
sequence was SAGSGK, in which the first S residue was required
for the trans-splicing reaction, and the last K residue was used to
attach the labeling group. The middle four residues were included
as a linker to provide additional distance between the C-intein and
the bulky 5-carboxyfluorescein, but this additional distance might
not be necessary when the labeling group is small and does not
interfere with the intein function. Indeed, protein C-terminal
biotinylation was achieved in this study using the IC-B peptide
having only a 3-aa linker.
The C-terminal labeling method of this study showed a relatively
high (75%) efficiency of the desired trans-splicing reaction with only
a negligible amount (,2%) of the undesired N-cleavage side
reaction, when compared to previous trans-splicing methods using
other inteins. For example, much lower (,40%) efficiencies were
reported for the Ssp DnaE split-intein [36], the Sce VMA split-intein
[37], and the Ssp DnaB S1 split-intein [26], and the latter intein also
exhibited a high level (20–40%) of the undesired N-cleavage side
reaction [26,29]. The labeling reaction in this study showed a
pseudo first-order rate constant of (3.860.6)610
25 s
21 under
optimal conditions, which is within the range of previously reported
rate constants of split-inteins used in protein labeling reactions
[26,34,38]. We used 45–250 micromolar concentrations of the
labeling peptides to achieve high efficiencies of the protein labeling,
which is similar to the other protein trans-splicing reactions.
Decreasing the peptide concentration to the nanomolar range did
Figure 7. Immobilization of biotinylated enhanced green fluorescent protein (E
B) to a solid surface. A, The biotinylation-purification
method. The precursor protein (EINC) in a cell lysate is first bound to chitin beads through its chitin binding domain (C). After washing away the
unbound proteins, the beads are incubated with the peptide IC-B that consists of IC followed by the sequence SAGSK with biotin linked to the lysine
(K) side chain. A trans-splicing reaction produces the biotinylated target protein (E
B) that can bind to streptavidin-coated beads (S). In the
experimental proof, streptavidin-coated beads were incubated either with the EINC precursor in a cell lysate (panels 1 and 2) or with the biotinylated
and purified E
B protein (panels 3 and 4). Panels 1 and 3 are differential interference contrast images, while panels 2 and 4 are fluorescence
micrographs (45 ms exposure time). B, The biotinylation-fixation method. The IC-B peptide is first bound to streptavidin-coated beads and then
incubated with the precursor protein EINC in a cell lysate to achieve trans-splicing, and the resulting biotinylated target protein (E
B) is automatically
fixed to the beads. In the experimental demonstration, streptavidin-coated beads with (panels 3 and 4) or without (panels 1 and 2) the pre-bound IC-B
peptide were incubated with the EINC protein in an E. coli cell lysate for trans-splicing. After washing away unbound proteins, the beads were
photographed as differential interference contrast images (panels 1 and 3) or as fluorescence images (panels 2 and 4, 600 ms exposure time).
doi:10.1371/journal.pone.0008381.g007
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conditions used in this study (data not shown).
Our trans-splicing method also exhibited generality and
versatility for protein C-terminal labeling. We have successfully
demonstrated this method with three different target proteins
(MBP, eGFP, and GST-ACP) and two different labeling groups
(fluorescein, biotin). We showed that the N-intein could tolerate
the C-terminal fusion of an affinity binder for easy purification of
the precursor protein. The affinity binder was a chitin-binding
domain or a hexa-histidine tag in this study, but potentially it
could also be others such as glutathione-S-transferase. The affinity
binder is conveniently removed along with the N-intein in the
Figure 8. Labeling of transferrin receptor (TfR) protein on live cells. A. Expression of the TfR-intein fusion protein. CHO-TRVb cells, which are
Chinese hamster ovary cells deficient for endogenous TfR, were transfected with plasmid pcTR-HA expressing a human TfR fused to a C-terminal HA
tag, plasmid pcTR-IN-HA expressing the TfR fused to IN and the HA tag (TfR-IN-HA fusion protein), or plasmid pcDNA3.1 as an empty vector, as
indicated. On the left are confocal microscopy images of immunofluorescence using antibodies against the HA tag (a-HA), and the cells were
counterstained with rhodamine-phalloidin for actin. On the right are Western blots using a-HA or a-TfR antibodies, with the monomeric and dimeric
forms of the receptor proteins indicated. B, Function of the TfR-intein fusion protein. On the left, CHO-TRVb cells transfected with the indicated
plasmids were incubated with rhodamine-labeled transferrin (Rh-Tf) to show function of the TfR-intein fusion protein in cellular uptake of transferrin.
The cells were counterstained using antibodies against tubulin. On the right, cells transfected with the pcTR-IN-HA plasmid were incubated with Rh-
Tf and also visualized by immunofluorescence using a-HA antibodies, which showed co-localization of the TfR-IN-HA fusion protein with Rh-Tf. The
cells were counterstained with TO-PRO-3 for the nucleus. C. Observation of labeling of TfR. CHO-TRVb cells transfected with the indicated plasmids
were incubated with increasing amounts (as indicated) of the fluorescent IC-L peptide (described in Figure 2). Only cells expressing the TfR-intein
fusion protein from the pcTR-IN-HA plasmid showed discrete green fluorescent spots, indicating successful labeling of TfR. The cells were
counterstained with rhodamine-phalloidin for actin in the confocal microscopy.
doi:10.1371/journal.pone.0008381.g008
Intein-Based Protein Labeling
PLoS ONE | www.plosone.org 9 December 2009 | Volume 4 | Issue 12 | e8381subsequent trans-splicing reaction for C-terminal labeling. This
allowed us to carry out the labeling reaction with the precursor still
bound to a protein purification column, which labeled and
simultaneously released the target protein from the column,
making this the first method of labeling and purifying a target
protein in one step. We demonstrated C-terminal biotinylation of
a protein either in solution or on a solid surface, which allowed
site-specific (i.e. C-terminal) immobilization of the biotinylated
target protein on a streptavidin-coated surface. We also achieved
protein-specific biotinylation and immobilization in a complex
protein mixture (E. coli cell lysate) without purifying the precursor
protein, which is a considerable advantage of this method for high-
throughput protein immobilization on protein chips. Finally, we
were able to label a membrane receptor protein on the surface of a
live mammalian cell, because the labeling (trans-splicing) reaction
could occur under nearly physiological conditions.
In conclusion, we have produced an efficient and useful method
for the C-terminal labeling of recombinant proteins, using an
intein-catalyzed trans-splicing reaction between a protein and a
small synthetic peptide carrying the desired labeling groups. This
method has a number of unique advantages over previously
reported methods and is expected to have many potential
applications in protein engineering and research. Adding a
fluorophore to the C-terminus of a protein, both in solution and
on the membrane surface of a live cell, can be a useful tool for
monitoring protein folding, location, and trafficking in cells. The
C-terminal biotinylation of a protein can be a superior way of
protein fixation on streptavidin-coated surfaces including protein
microchips used in proteomics. Potentially many other chemical
groups can be added to the C-terminus of proteins using this
method, which is limited only by the ability of chemical synthesis
to produce the small C-intein peptide containing the desired
chemical groups.
Materials and Methods
Plasmid construction and protein purification
Plasmid pMINC was constructed by replacing the Ssp DnaB
intein sequence in the pMST plasmid [39] with coding sequence
of the Ssp GyrB S11 IN, and replacing the thioredoxin sequence
with coding sequence of the chitin binding domain. Plasmid
pTEINC was constructed by replacing the double-intein ORF of
the pTWIN vector (New England Biolabs) with the coding
sequences of enhanced green fluorescent protein, followed by the
Ssp GyrB S11 IN and the chitin binding domain. In plasmid
pTEINH, the chitin binding domain coding sequence of pTEINC
was replaced with a sequence for a hexahistidine tag. The plasmid
pGST-ACP-INC was obtained by cloning the coding sequence for
the Ssp GyrB S11 IN (followed by the chitin binding domain)
downstream of the V. harveyi ACP in plasmid pGEX-F50W [40].
Plasmid pcTR-IN-HA was constructed by fusing the Ssp GyrB S11
IN with a C-terminal HA epitope tag to the coding sequence of the
human transferrin receptor, and cloning the fusion gene into the
mammalian expression vector pcDNA3.1. Plasmid pcTR-HA is
similar to pcTR-IN-HA but lacks the coding sequence of the Ssp
GyrB S11 IN fragment.
The MINC precursor protein was expressed from plasmid
pMINCi nE. coli DH5a cells and purified by amylose affinity
chromatography according to the manufacturer’s guidelines (New
England Biolabs). The EINH and GST-ACP-INC proteins were
over expressed in BL21(DE3)pLysS cells and purified on Ni-NTA
agarose (Qiagen) and Glutathione Sepharose 4B (GE Healthcare),
respectively, using standard procedures.
In vitro protein labeling
For fluorescent labeling, ,5 mMM I NC protein was incubated
with 125 mM peptide IC-L (sequence: GVFVHNSAGSGK-(5-
carboxyfluorescein) purchased from New England Peptide) in
optimized Splicing Buffer (oSB: 20 mM Tris-HCl, 250 mM NaCl,
1 mM EDTA; pH 8.5) in the presence or absence of 0.1 mM
TCEP for 16 h at room temperature. Reactions were stopped with
SDS sample buffer, and samples were run on a 12.5% SDS-PAGE
gel in the dark. After completion of electrophoresis, the gel was
equilibrated in 10% ethanol/7% acetic acid and scanned for
fluorescence using the Typhoon 9410 equipment (Amersham
Biosciences) with excitation wavelength of 488 nm and an
emission filter for 520 nm. Afterwards, the gel was stained with
Coomassie Brilliant Blue and destained using standard procedures.
For biotinylation, ,5 mM precursor proteins were incubated with
250 mM peptide IC-B (sequence: GVFVHNSAGSK-biotin, pur-
chased from New England Peptide) in oSB in the presence of
0.1 mM TCEP. Reactions were separated by 12.5% SDS-PAGE,
and subjected to Western blotting using mouse anti-Biotin
antibody (Sigma Aldrich). Additional Western blotting was carried
out with antibodies against the chitin binding domain (mouse anti-
C antibody) and the His-tag (mouse anti-H antibody), which were
purchased from New England Biolabs and Sigma Aldrich,
respectively. All primary antibodies were used in combination
with a secondary rabbit-anti mouse IgG HRP-linked antibody (GE
Healthcare). Chemiluminescence was performed with the ECL
Plus Western Detection Kit according to manufacturor’s guide-
lines (GE Healthcare).
Simultaneous protein purification and labeling
Precursor proteins MINCa n dE I NC were expressed in E. coli
DH5aandBL21(DE3),respectively,andthecellswerelysedinoSB.
The soluble fraction of the cell lysate was loaded onto chitin resin.
After washing away unbound proteins with oSB, the resin was
incubatedin oSBcontaining 0.1 mM TCEP and either 45 mMI C-L
(for MINC protein) or 125 mMI C-B (for EINC protein, sequence:
GVFVHNSAGSK-biotin, purchased from GenScript), and the
incubation was continued overnight at room temperature. Proteins
released from the resin were collected and further purified using a
small amount of freshly equilibrated chitin resin. The purified
protein was then concentrated using Amicon Ultra Centrifugal
Filter Devices (Millipore) and analyzed by SDS-PAGE as above.
Reversed-phase high-performance liquid
chromatography (RP-HPLC)
The concentrated eluate from on-column labeling of MINC with
IC-L (,50 mg protein) was incubated with 1 mg Factor Xa (New
England Biolabs) in oSB for 18 h at room temperature. Half of the
reactionwasanalyzed byreverse phaseHPLCusingaSpiritPeptide
C18 column (Aapptec: 5 mm, 2560.4 cm) and Beckman System
Gold equipment (Programmable Solvent Module 126, Program-
mable Detector Module 166, Software GoldV712). Mobile phase A
was 0.1% TFA in water, while mobile phase B was 0.1% TFA in
acetonitrile. A gradient was run (mobile phase B from 2% to 60% in
45 minutes), followed by 80% B for 5 min and re-equilibration with
2% B for 10 min. The flow rate was set to 0.8 mL/min and
detection was done at both 210 nm and 497 nm. The peptide
standard pep
Xa (sequence: GTLEGG; purchased from GenScript)
at a quantity of 10 nmol was analyzed in a similar fashion.
Mass spectrometry analysis (MS)
MS analysis was performed on (a) M
L protein excised from a
Coomassie-stained SDS-polyacrylamide gel and digested with
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without the liquid chromatography step, and (c) peptide products
of a labeling reaction after digestion with Factor Xa (see above).
For (a), the M
L-containing polyacrylamide gel slice was reduced
with DTT, carboxamidomethylated with iodoacetamide, and
digested with trypsin (Promega, sequencing grade) for 7.5 h at
37uC. Peptides were extracted with 70% acetonitrile and 1%
formic acid in HPLC-grade water. The reaction was automated on
a ProGest digestion robot (Genomic Solutions). The extraction
solvent was removed under vacuum using a speed vac, and tryptic
peptides were resuspended in 30 mL of 5% methanol, 0.5% formic
acid in HPLC-grade water. For (b), prior to sample injection, salts
and excess IC-L peptide were removed from the labeling reaction
sample using Zeba Micro Desalt Spin Columns (Pierce). For (c),
,50 mg of a protein labeling reaction was incubated with 1 mg
Factor Xa (New England Biolabs) in oSB for 18 h at room
temperature.
LC-MS/MS was performed using an Ultimate pump and
Famos auto-sampler (LC Packings, Amsterdam, Netherlands)
interfaced to the nanoflow ESI source of a hybrid triple
quadrupole linear ion trap (Qtrap) mass spectrometer (Applied
Biosystems, Foster City, CA, USA). Samples (3 mL) were injected
onto a capillary column (0.106150 mm Chromolith C18,
monolithic, Merck) at a flow rate of 1.2 mL/min. A linear gradient
was run (5% solvent B to 35% B over 35 min), followed by 90% B
for six minutes and re-equilibration at 5% B. Solvent A consisted
of 2% acetonitrile, 0.1% formic acid in water, solvent B was 98%
acetonitrile, 0.1% formic acid. The sample was sprayed through a
distal coated fused silica emitter tip (75 mm ID with 15 mm ID tip,
New Objectives PicoTip). The capillary voltage was 2.10 kV with a
declustering potential of 60 V, the curtain gas was set to 15
(arbitrary units). Spectra were acquired using the Information
Dependent Acquisition mode.
Kinetic analysis of the labeling reaction
The MINC precursor protein was incubated with the IC-L
peptide in the presence or absence of TCEP at room temperature
for 24 h, during which samples were removed from the reaction at
specific time points, and the reaction was stopped by addition of
SDS sample buffer. Samples were subjected to SDS-PAGE
followed by Western blotting analysis using anti-C antibody (see
above). Densitometry analysis of protein signals corresponding to
MINC and the INC fragment was performed with the program
ImageJ 1.342. Labeling efficiencies were calculated using the
formula (AINC/(AINC + AMINC))*100, where AX represents the
densitometry peak area of the respective protein signal. The
amount of INC fragment represented that of the spliced (labeled)
protein, because these two protein products from the splicing
reaction had essentially equal molar amounts (see Figure 4).
Densitometry analysis for end-point efficiencies was performed
similarly. For time-course analysis, the efficiencies were plotted as
a function of time, and pseudo-first order rate constants (kobs) were
determined as described for trans-splicing of the Ssp DnaE split-
intein[36] and using the program KaleidaGraph 4.02.
Activity of the fluorescence-labeled maltose binding
protein (M
L)
Amylose resin (New England Biolabs) was equilibrated with
Amylose Column Buffer (ACB: 20 mM Tris-HCl, 200 mM NaCl;
pH 7.4) and incubated for 1 h at 4uC with M
L protein. The resin
was then washed extensively with ACB (sixty-times resin volume),
and a small aliquot was viewed under a fluorescence microscope
(AxioVert 200M, Zeiss) with excitation at 489 nm and a filter for
emission at 520 nm. Proteins bound to the amylose resin were
then eluted with ACB + 10 mM maltose, and samples were
analyzed by SDS-PAGE, fluorescence scanning and Coomassie-
staining as described above.
C-terminal biotinylation of Enhanced Green Fluorescent
Protein (E
B)
Streptavidin-coated magnetic beads (Dynal Biotech) were
washed three times with PBS-T (10 mM sodium phosphate,
0.9% NaCl, 0.1% Tween-20; pH 7.4) and incubated with either
concentrated E
B protein (see above) or the soluble fraction from
pTEINC expression for 1 h at room temperature in the dark.
Alternatively, beads were treated with or without 500 mMI C-B
peptide for 1 h at room temperature before incubation with the
soluble pTEINC fraction in the presence of 0.1 mM TCEP for
18 h at room temperature. Unbound proteins were washed away,
and beads were resuspended in PBS-T and spotted onto a glass
slide for fluorescence microscopy as described.
Labeling of transferrin receptor on live cells
CHO-TRVb cells were cultured in F12 nutrient mixture
supplemented with 5% fetal bovine serum, 10 U/mL penicillin,
and 0.1 mg/mL streptomycin at 37uC in a humidified chamber
with an atmosphere of 5% CO2.
Actively growing cells (1.5610
5) were transfected with 0.5 mg
plasmid DNA using the MicroPorator MP-100 (Digital Bio) with
10 mL Gold tips and the following settings: 1560 V, 5 ms pulse
width, 10 pulses. Cells were seeded in 6-well plates and maintained
as above in culture medium without antibiotics. For subsequent
microscopy experiments, cells were seeded on sterilized cover slips.
For SDS-PAGE 24 h post-transfection, cells were washed once
with PBS,scraped gently fromthesurface ofthewellinto1 mLPBS,
and harvested by centrifugation (3,0006g, 2 min, RT). The cell
pellet was resuspended in a lysis buffer (0.5% sodium deoxycholate,
1% Triton X-100, 1 mM EDTA, 150 mM NaCl, 50 mM Tris-HCl
(pH 7.4) supplemented with a protease inhibitor cocktail (Bioshop)
prior to use) and lysed by sonication (7 pulses at output 2).
For immunofuorescence, transfected cells were washed three
times for 3 min each with 1 mL PBS, and fixed using 3.7%
formaldehyde in PBS. After an additional wash step with PBS,
cells were permeabilized with 0.05% Triton X-100 in PBS for
9 min at 220uC, and washed again with PBS. After blocking for
30 min with PBS-B (3% BSA in PBS), cells were incubated with
primary antibody (a-HA diluted 1:250, a-tubulin bIII both diluted
1:1,000 in PBS-B) for 1 h at RT. After washing with PBS-B, cells
were incubated with secondary antibody (goat anti-mouse IgG,
conjugated with AlexaFluor 488 (Molecular Probes) and diluted
1:2,000 in PBS-B) for 45 min at RT. Cells were finally washed
three times with PBS, and coverslips were mounted on Superfrost
Plus Microscopic Slides (Thermo Scientific) using Mowiol 4–88.
Depending on the experiment, cells were counterstained for actin
by adding rhodamine-phalloidin (10 ng/mL final concentration) to
the secondary antibody solution. Nuclear DNA was sometimes
stained by incubating coverslips with 100 nM TO-PRO-3
(Molecular Probes) for 5 min at RT prior to mounting. Cell
imaging was performed on a LSM510 META Laser Scanning
Microscope (Zeiss) at 1006 magnification with excitation
wavelength/band-path filter pairs (nm/nm) of 488/530 (Ar laser),
543/585 (HeNe laser) and 633/650 (HeNe laser), respectively.
Uptake of transferrin was assessed by incubating transfected
cells 24 h post-transfection with tetramethylrhodamine-labeled
human holo-transferrin (Molecular Probes), diluted to 15 mg/mL
in F12 nutrient mixture containing 5% FBS, for 5–15 min at
37uC. Cells were then subjected to immunofluorescence as
described above.
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were washed twice with PBS, overlaid with labeling solution
(buffer HBS (124 mM NaCl, 3 mM KCl, 5 mM D-glucose,
10 mM HEPES (pH 7.4), 2 mM CaCl2, 1 mM MgCl2) containing
0.1 mM TCEP and various concentrations of peptide IC-L) and
incubated for 18 h at 23uC/5% CO2. Cells were then prepared for
microscopy by fixation, permeabilization, and counterstaining
with rhodamine-phalloidin as described above.
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